Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / MRTX - Better Buy: Amgen vs. Mirati Therapeutics


MRTX - Better Buy: Amgen vs. Mirati Therapeutics

Investors looking for biotech stocks to buy will notice lots of buzz around Amgen (NASDAQ: AMGN) and Mirati Therapeutics (NASDAQ: MRTX) lately. Both companies are developing similar new cancer treatments that could go on to generate billions in annual sales, and there are plenty of arguments over which company has the best one.

Which one of these stocks is a better fit for your portfolio? Let's have a look at the case for each to weigh their chances to provide outsize returns.

Image source: Getty Images.

Continue reading

For further details see:

Better Buy: Amgen vs. Mirati Therapeutics
Stock Information

Company Name: Mirati Therapeutics Inc.
Stock Symbol: MRTX
Market: NASDAQ
Website: mirati.com

Menu

MRTX MRTX Quote MRTX Short MRTX News MRTX Articles MRTX Message Board
Get MRTX Alerts

News, Short Squeeze, Breakout and More Instantly...